AMENDMENT NO. 2 TO SCHEDULE 13D
Explanatory Note
This Amendment No. 2 (“Amendment No. 2”) amends and supplements the Schedule 13D (the “Original Schedule 13D”) filed on March 26, 2020, as amended by that certain Amendment No. 1 to the Original Schedule 13D (“Amendment No. 1”), filed on November 23, 2020 and as amended through this Amendment No. 2 (the “Schedule 13D”). Except as specifically amended by this Amendment No. 2, the Schedule 13D remains in full force and effect. Capitalized terms used but not otherwise defined herein shall have the respective meanings previously ascribed to them in the Schedule 13D.
Item 5. Interest in Securities of the Issuer
Item 5 of this Schedule 13D is hereby amended and supplemented to include the following:
(a) As of the date hereof, the Reporting Persons beneficially own 24,318,627 shares of Common Stock, representing 56.8% of the outstanding shares.
The ownership percentage appearing on such cover pages has been calculated based on an aggregate total of 33,407,806 shares of Common Stock issued and outstanding as of November 1, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021, plus 9,386,282 shares of Common Stock beneficially owned by the Reporting Persons underlying the Series A Preferred Stock.
(b) See items 1 through 10 of the cover pages to this Statement for the number of shares of Common Stock beneficially owned by each of the Reporting Persons as to which there is sole or shared power to vote or to direct the vote, and sole or shared power to dispose or to direct the disposition.
(c) Since the filing of Amendment No. 1, the Reporting Persons have sold a total of 523,576 shares of Common Stock, for an aggregate sales price of $2,591,308.53, which amount excludes commissions and other execution-related costs. Except for the transactions set forth in Schedule I, the Reporting Persons have not effected any transaction in Common Stock during the past 60 days. All such transactions were effected in the open market pursuant to a 10b5-1 sales plan.
(d) To the best knowledge of the Reporting Persons, no other person besides the Reporting Persons or the partners, members, affiliates or shareholders of the Reporting Persons, has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities of the Issuer reported herein.
(e) Not applicable.